US 7452995
Aryl aniline β2 adrenergic receptor agonists
granted A61PA61P43/00
Quick answer
US patent 7452995 (Aryl aniline β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P43/00